Targeting metabolic reprogramming in metastatic melanoma: The key role of nicotinamide phosphoribosyltransferase (NAMPT).

Audrito, Valentina; Managò, Antonella; Gaudino, Federica; Deaglio, Silvia

Audrito, Valentina; Managò, Antonella; Gaudino, Federica; Deaglio, Silvia.

Afiliação

Audrito V; Department of Medical Sciences, University of Turin, Turin, Italy; Italian Institute for Genomic Medicine, Turin, Italy. Electronic address: valentina.audrito@unito.it.
Managò A; Department of Medical Sciences, University of Turin, Turin, Italy; Italian Institute for Genomic Medicine, Turin, Italy.
Gaudino F; Department of Medical Sciences, University of Turin, Turin, Italy; Italian Institute for Genomic Medicine, Turin, Italy.
Deaglio S; Department of Medical Sciences, University of Turin, Turin, Italy; Italian Institute for Genomic Medicine, Turin, Italy. Electronic address: silvia.deaglio@unito.it.

Semin Cell Dev Biol ; 98: 192-201, 2020 02.

Article em En | MEDLINE | ID: mdl-31059816

Assuntos

Melanoma/metabolismo; Nicotinamida Fosforribosiltransferase/metabolismo; Animais; Humanos; Melanoma/patologia; Melanoma/secundário

Palavras-chave

BRAF; Combination therapy; Melanoma; Metabolic reprogramming; NAD(+)metabolism; NAMPT

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nicotinamida Fosforribosiltransferase / Melanoma Limite: Animals / Humans Idioma: En Revista: Semin Cell Dev Biol Assunto da revista: EMBRIOLOGIA Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google